Eagle Claw Capital Managment, LLC Novo Nordisk A S Transaction History
Eagle Claw Capital Managment, LLC
- $602 Million
- Q1 2025
A detailed history of Eagle Claw Capital Managment, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Eagle Claw Capital Managment, LLC holds 65,150 shares of NVO stock, worth $4.41 Million. This represents 0.75% of its overall portfolio holdings.
Number of Shares
65,150
Previous 65,850
1.06%
Holding current value
$4.41 Million
Previous $5.66 Million
20.13%
% of portfolio
0.75%
Previous 0.95%
Shares
29 transactions
Others Institutions Holding NVO
# of Institutions
1,769Shares Held
330MCall Options Held
11.3MPut Options Held
15.5M-
Jennison Associates LLC18.8MShares$1.27 Billion0.93% of portfolio
-
Bank Of America Corp Charlotte, NC14.8MShares$1 Billion0.08% of portfolio
-
Loomis Sayles & CO L P12.4MShares$839 Million1.24% of portfolio
-
Morgan Stanley New York, NY12.3MShares$834 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11.9MShares$804 Million0.36% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $153B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...